Reading Time: 3 minutes There is nine times more water in the air around us than in all the oceans combined. Technology is helping us harvest it.
Reading Time: 7 minutes Nearly every person in San Francisco has health insurance. Can the city’s program serve as a model for the rest of the country?
Reading Time: 8 minutes There is a recognized process for documenting the medical evidence of rape. When followed correctly, it often leads to a criminal conviction. Unfortunately not enough hospitals have nurses trained to do it. Will Congress act?
Reading Time: 3 minutes Breakthrough analytical methods are proving how your microbiome — all the bacteria in your body — can hold the key to health and happiness.
Reading Time: 3 minutes When the brain is damaged, patients can regain speech and movement with the aid of Neurologic Music Therapy.
Reading Time: 2 minutes The head of the NIH claims an AIDS-free world is on the horizon. But administering drugs is the easy part — educating populations less so.
Reading Time: 8 minutes If you thought tighter restrictions were helping to solve the opioid crisis, think again. Some patients, pain doctors, and groups are pushing back.
Reading Time: 2 minutes The peculiar amphibian is somehow impervious to lethal levels of a jaundice-causing toxin — the pigment responsible for its green color.
Reading Time: 7 minutes A small group with ties to President Donald Trump’s opioid czar has just been awarded $24 million in federal grants.
Reading Time: 7 minutes In his State of the Union address, President Donald Trump urged Congress to pass a controversial bill promising greater access to untested drugs for terminally ill patients. But critics charge the bill would only deliver false hope and result in even less patient protection by removing FDA oversight.
Reading Time: 3 minutes After a federal official told staff not to use certain words in budget documents, the pushback was huge. But there might have been a method to this madness.
Reading Time: 6 minutes “Right to Try” legislation would allow pharmaceutical companies to give experimental drugs to desperate patients — with no chance of being liable if things go wrong. Supporters of the measure cheer this approach but critics see dangers.
Reading Time: 4 minutes Now that ebola hysteria has stopped interrupting regular programming and the American patients are cured, the risk is gone, right? Not so fast …